Literature DB >> 34704554

Proceed with care: the "uncommon" serologic weak D phenotypes.

Willy Albert Flegel1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 34704554      PMCID： PMC8297679          DOI： 10.2450/2021.0147-21

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  73 in total

1.  Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens.

Authors:  G L Daniels; A Fletcher; G Garratty; S Henry; J Jørgensen; W J Judd; C Levene; C Lomas-Francis; J J Moulds; J M Moulds; M Moulds; M Overbeeke; M E Reid; P Rouger; M Scott; P Sistonen; E Smart; Y Tani; S Wendel; T Zelinski
Journal:  Vox Sang       Date:  2004-11       Impact factor: 2.144

2.  Six years' experience performing RHD genotyping to confirm D- red blood cell units in Germany for preventing anti-D immunizations.

Authors:  Willy A Flegel; Inge von Zabern; Franz F Wagner
Journal:  Transfusion       Date:  2009-03       Impact factor: 3.157

3.  An easy RHD genotyping strategy for D- East Asian persons applied to Korean blood donors.

Authors:  Timo A Luettringhaus; Duck Cho; Dong Wook Ryang; Willy A Flegel
Journal:  Transfusion       Date:  2006-12       Impact factor: 3.157

Review 4.  Pathogenesis and mechanisms of antibody-mediated hemolysis.

Authors:  Willy A Flegel
Journal:  Transfusion       Date:  2015-07       Impact factor: 3.157

Review 5.  Haemolytic disease of the fetus and newborn.

Authors:  M de Haas; F F Thurik; J M Koelewijn; C E van der Schoot
Journal:  Vox Sang       Date:  2015-04-20       Impact factor: 2.144

6.  Production of RBC autoantibody mimicking anti-D specificity following transfusion in a patient with weak D Type 15.

Authors:  Chikako Takeuchi-Baba; Shoichi Ito; Rie Kinjo; Hitomi Miyagi; Hiroyasu Yasuda; Kenichi Ogasawara; Hitoshi Ohto
Journal:  Transfusion       Date:  2019-02-19       Impact factor: 3.157

7.  Predisposing factors for anti-D immune response in D- patients with chronic liver disease transfused with D+ platelet concentrates.

Authors:  Nicolas Burin des Roziers; Philippe Chadebech; Lucile Malard; Benoit Vingert; Philippe Gallon; Didier Samuel; Rachid Djoudi; Anne-Marie Fillet; France Pirenne
Journal:  Transfusion       Date:  2019-01-03       Impact factor: 3.157

8.  Strategies to identify candidates for D variant genotyping.

Authors:  Xunda Luo; Margaret A Keller; Ian James; Michelle Grant; Shiguang Liu; Kellie Simmons Massey; Andrew Czulewicz; Sandra Nance; Yanhua Li
Journal:  Blood Transfus       Date:  2017-04-05       Impact factor: 3.443

9.  Relevance and costs of RHD genotyping in women with a weak D phenotype.

Authors:  L Laget; C Izard; E Durieux-Roussel; J Gouvitsos; I Dettori; J Chiaroni; V Ferrera-Tourenc
Journal:  Transfus Clin Biol       Date:  2018-06-01       Impact factor: 1.406

10.  RHD positive haplotypes in D negative Europeans.

Authors:  F F Wagner; A Frohmajer; W A Flegel
Journal:  BMC Genet       Date:  2001-07-16       Impact factor: 2.797
View more
  2 in total

1.  Transfusion support for a woman with RHD*09.01.02 and the novel RHD*01W.161 allele in trans.

Authors:  K Srivastava; M U Bueno; W A Flegel
Journal:  Immunohematology       Date:  2022-04-29

2.  A practical and effective strategy in East Asia to prevent anti-D alloimmunization in patients by C/c phenotyping of serologic RhD-negative blood donors.

Authors:  Shoichi Ito; Hitoshi Ohto; Yoshiko Ogiyama; Michiyo Irino; Susumu Omokawa; Itaru Shibasaki; Kenichi Ogasawara; Makoto Uchikawa; Kenneth E Nollet; Willy A Flegel
Journal:  EJHaem       Date:  2021-09-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.